Clinical pharmacology of oral gemcitabine in patients with advanced solid tumors

被引：0
|
作者：
Veltkamp, S. A.
Callies, S.
Nol, A.
Visseren-Grul, C. M.
Slapak, C.
Beijnen, J. H.
Schellens, J. H. M.
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：735 / 735
页数：1
相关论文
共 50 条
  • [21] Dose finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors
    Di Paola, E. Donato
    Alonso, S.
    D'Alessio, A.
    Giuliani, R.
    Calabro, F.
    Messina, C.
    Zivi, A.
    Squilloni, E.
    De Marco, S.
    Sternberg, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    William Schelman
    Sherry Morgan-Meadows
    Howard Bailey
    Kyle Holen
    James P. Thomas
    Jens Eickhoff
    Heidi Brandon
    Kate Oliver
    Dona Alberti
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 727 - 733
  • [23] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [24] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    Schelman, William
    Morgan-Meadows, Sherry
    Bailey, Howard
    Holen, Kyle
    Thomas, James P.
    Eickhoff, Jens
    Brandon, Heidi
    Oliver, Kate
    Alberti, Dona
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (04) : 727 - 733
  • [25] WEEKLY GEMCITABINE IN ADVANCED OR METASTATIC SOLID TUMORS - A CLINICAL-PHASE-I STUDY
    POLLERA, CF
    CERIBELLI, A
    CRECCO, M
    CALABRESI, F
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (02) : 111 - 119
  • [26] Clinical pharmacology of dose escalation of intravenous treosulfan with autologous stem cell support in patients with advanced solid tumors
    Hilger, RA
    Harstrick, A
    Oberhoff, C
    Skorzec, M
    Baumgart, J
    Seeber, S
    Scheulen, ME
    BONE MARROW TRANSPLANTATION, 1998, 22 : S51 - S55
  • [27] Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors
    Patnaik, Amita
    Tolcher, Anthony
    Beeram, Murali
    Nemunaitis, John
    Weiss, Glen J.
    Bhalla, Kapil
    Agrawal, Manish
    Nichols, Gwen
    Middleton, Steven
    Beryozkina, Anna
    Sarapa, Nenad
    Peck, Richard
    Zhi, Jianguo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 587 - 595
  • [28] Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors
    Amita Patnaik
    Anthony Tolcher
    Murali Beeram
    John Nemunaitis
    Glen J. Weiss
    Kapil Bhalla
    Manish Agrawal
    Gwen Nichols
    Steven Middleton
    Anna Beryozkina
    Nenad Sarapa
    Richard Peck
    Jianguo Zhi
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 587 - 595
  • [29] Phase I safety and tolerability of once daily oral afatinib (A) in combination with gemcitabine (G) in patients with advanced solid tumors.
    Zanetta, Sylvie
    Bennouna, Jaafar
    Isambert, Nicolas
    De-Montserrat, Helene
    Squiban, Patrick J.
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Koolen, Stijn L. W.
    Witteveen, Petronella O.
    Jansen, Robert S.
    Langenberg, Marlies H. G.
    Kronemeijer, Roelien H.
    Nol, Annemarie
    Garcia-Ribas, Ignacio
    Callies, Sophie
    Benhadji, Karim A.
    Slapak, Christopher A.
    Beijnen, Jos H.
    Voest, Emile E.
    Schellens, Jan H. M.
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 6071 - 6082
12345